Cargando…

Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells

Cancer stem cells (CSCs) in hepatocellular carcinoma (HCC) are frequently resistant to current therapeutic regimens and therefore responsible for tumor recurrence. Previous studies have reported that expression levels of dysadherin in CSCs may be used as a prognostic indicator, which is also respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	JIANG, NAN, CHEN, WEI, ZHANG, JIAN-WEN, LI, YANG, ZENG, XIAN-CHENG, ZHANG, TONG, FU, BIN-SHENG, YI, HUI-MIN, ZHANG, QI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626168/ https://www.ncbi.nlm.nih.gov/pubmed/26458963 http://dx.doi.org/10.3892/mmr.2015.4363

Ejemplares similares

Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma
por: Wu, Zhengchun, et al.
Publicado: (2020)

Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis
por: Bilajac, Esma, et al.
Publicado: (2022)

Prognostic significance of dysadherin expression in advanced colorectal carcinoma
por: Aoki, S, et al.
Publicado: (2003)

Involvement of dysadherin and E-cadherin in the development of testicular tumours
por: Batistatou, A, et al.
Publicado: (2005)

STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B-Cell Lymphoma
por: Hardee, Jennifer, et al.
Publicado: (2013)

Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma
por: Lu, Ting, et al.
Publicado: (2016)

T‐cell lymphoma, B‐cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone
por: Yoshihara, Kyoko, et al.
Publicado: (2021)

Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma
por: Zhang, Xuzhao, et al.
Publicado: (2022)

In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin
por: Batistatou, A, et al.
Publicado: (2007)

Dysadherin awakens mechanical forces and promotes colorectal cancer progression
por: Park, So-Yeon, et al.
Publicado: (2022)

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas
por: Tsuyama, Naoko, et al.
Publicado: (2017)

CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
por: Gong, Yuqi, et al.
Publicado: (2023)

B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma
por: King, Amber Loren O., et al.
Publicado: (2020)

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
por: Blix, Egil S, et al.
Publicado: (2012)

Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2015)

Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
por: Pommerenke, C, et al.
Publicado: (2016)

UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
por: Li, Xiaoxi, et al.
Publicado: (2018)

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2023)

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
por: Gebauer, Niklas, et al.
Publicado: (2021)

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2015)

Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases
por: Zhang, Shanxiang, et al.
Publicado: (2015)

Aggressive B-Cell Lymphomas
por: Naresh, Kikkeri N., et al.
Publicado: (2012)

Large B-cell lymphomas
por: Vitolo, Umberto
Publicado: (2019)

Differential diagnosis of sinonasal extranodal NK/T cell lymphoma and diffuse large B cell lymphoma on MRI
por: Chen, Yun, et al.
Publicado: (2020)

RBFOX2 and alternative splicing in B-cell lymphoma
por: Quentmeier, Hilmar, et al.
Publicado: (2018)

Targeting the Bcl-2 Family in B Cell Lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Expression of B-cell Lymphoma 2 in Breast Cancer
por: Bashir, Sehar, et al.
Publicado: (2021)

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma
por: Lenz, Georg, et al.
Publicado: (2007)

Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes
por: Jang, Samuel, et al.
Publicado: (2017)

Prognostic value of dysadherin in cancer: A systematic review and meta-analysis
por: Niinivirta, Aino, et al.
Publicado: (2022)

Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
por: Nagai, Shin, et al.
Publicado: (2018)

Composite lymphoma of concurrent T zone lymphoma and large cell B cell lymphoma in a dog
por: Matsuyama, Arata, et al.
Publicado: (2019)

Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas
por: Min, Soo Kee, et al.
Publicado: (2012)

Imaging findings for intravascular large B-cell lymphoma of the liver
por: Bae, Jungmin, et al.
Publicado: (2015)

Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma
por: Ricker, Edd, et al.
Publicado: (2020)

Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma: An In Silico Approach
por: Vick, Eric J., et al.
Publicado: (2018)

Copy number aberrations in B-cell lymphoma: A call for consideration in prognosis determination and therapy
por: Kertowidjojo, Elizabeth, et al.
Publicado: (2019)

High-grade B-cell lymphoma with 11q aberrations: A single-center study
por: Yamada, Shoki, et al.
Publicado: (2023)

Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B‐cell Lymphoma and NK/T‐cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2023)

Effect of nucleolin on adriamycin resistance via the regulation of B‐cell lymphoma 2 expression in Burkitt's lymphoma cells
por: Mei, Xuqiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jg2uqc39dl5he98tc91707a8l1